Clinical Trial Update: Study of Pamiparib in Newly Diagnosed and rGBM [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating pamiparib in newly diagnosed and recurrent glioblastoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pamiparib (pamiparib)

Snippet

Sponsor: Nader Sanai | Conditions: Glioblastoma, Glioblastoma Multiforme | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING